Medicare beneficiaries at high risk for severe COVID-19 received less treatment. A new study examines why

A recently published study in the JAMA Health Forum of a cross-section of patients enrolled in Medicare in 2022, found that those at the highest risk for severe COVID-19 infection received COVID-19 therapy less often than those with the least risk. “We went into the study to find out why adoption of an effective COVID-19 […] Read More